Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System from the United States Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback